Skip to main content
. 2011 Dec 15;6(1):Doc25. doi: 10.3205/dgkh000182

Figure 2. Costs of pharmaceuticals per insured with (MRE+) and without (MRE-) infections induced by multi-resistant bacteria 2007–2009.

Figure 2